Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198

1.

Applications of the oral microbiome in personalized dentistry.

Belibasakis GN, Bostanci N, Marsh PD, Zaura E.

Arch Oral Biol. 2019 Aug;104:7-12. doi: 10.1016/j.archoralbio.2019.05.023. Epub 2019 May 24. Review.

PMID:
31153099
2.

Enrichment of periodontal pathogens from the biofilms of healthy adults.

Naginyte M, Do T, Meade J, Devine DA, Marsh PD.

Sci Rep. 2019 Apr 2;9(1):5491. doi: 10.1038/s41598-019-41882-y.

3.

Differences in monocyte: lymphocyte ratio and Tuberculosis disease progression in genetically distinct populations of macaques.

Sibley L, Gooch K, Wareham A, Gray S, Chancellor A, Dowall S, Bate S, Marriott A, Dennis M, White AD, Marsh PD, Fletcher H, Sharpe S.

Sci Rep. 2019 Mar 4;9(1):3340. doi: 10.1038/s41598-019-39819-6.

4.

Changing the Paradigm of Daily Prevention to Achieve Whole Mouth Health in the 21st Century.

Cummins D, Marsh PD.

J Clin Dent. 2018 Sep;29(Spec No A):A1-9.

PMID:
30620865
5.

In Sickness and in Health-What Does the Oral Microbiome Mean to Us? An Ecological Perspective.

Marsh PD.

Adv Dent Res. 2018 Feb;29(1):60-65. doi: 10.1177/0022034517735295. Review.

6.
7.

Resilience of the Oral Microbiota in Health: Mechanisms That Prevent Dysbiosis.

Rosier BT, Marsh PD, Mira A.

J Dent Res. 2018 Apr;97(4):371-380. doi: 10.1177/0022034517742139. Epub 2017 Dec 1. Review.

8.

Root Surface Biofilms and Caries.

Do T, Damé-Teixeira N, Naginyte M, Marsh PD.

Monogr Oral Sci. 2017;26:26-34. doi: 10.1159/000479304. Epub 2017 Oct 19.

PMID:
29050018
9.

Novel methodology for determining the effect of adsorbates on human enamel acid dissolution.

Pechlivani N, Devine DA, Marsh PD, Mighell A, Brookes SJ.

Arch Oral Biol. 2018 Jan;85:46-50. doi: 10.1016/j.archoralbio.2017.09.035. Epub 2017 Oct 3.

10.

Ecological Therapeutic Opportunities for Oral Diseases.

Hoare A, Marsh PD, Diaz PI.

Microbiol Spectr. 2017 Aug;5(4). doi: 10.1128/microbiolspec.BAD-0006-2016. Review.

11.

Dental caries.

Pitts NB, Zero DT, Marsh PD, Ekstrand K, Weintraub JA, Ramos-Gomez F, Tagami J, Twetman S, Tsakos G, Ismail A.

Nat Rev Dis Primers. 2017 May 25;3:17030. doi: 10.1038/nrdp.2017.30. Review.

12.

An aerosol challenge model of tuberculosis in Mauritian cynomolgus macaques.

Sharpe SA, White AD, Sibley L, Gleeson F, Hall GA, Basaraba RJ, McIntyre A, Clark SO, Gooch K, Marsh PD, Williams A, Dennis MJ.

PLoS One. 2017 Mar 8;12(3):e0171906. doi: 10.1371/journal.pone.0171906. eCollection 2017.

13.

Dental biofilm: ecological interactions in health and disease.

Marsh PD, Zaura E.

J Clin Periodontol. 2017 Mar;44 Suppl 18:S12-S22. doi: 10.1111/jcpe.12679. Review.

14.

Role of microbial biofilms in the maintenance of oral health and in the development of dental caries and periodontal diseases. Consensus report of group 1 of the Joint EFP/ORCA workshop on the boundaries between caries and periodontal disease.

Sanz M, Beighton D, Curtis MA, Cury JA, Dige I, Dommisch H, Ellwood R, Giacaman RA, Herrera D, Herzberg MC, Könönen E, Marsh PD, Meyle J, Mira A, Molina A, Mombelli A, Quirynen M, Reynolds EC, Shapira L, Zaura E.

J Clin Periodontol. 2017 Mar;44 Suppl 18:S5-S11. doi: 10.1111/jcpe.12682.

15.

A randomised clinical study to determine the effect of a toothpaste containing enzymes and proteins on plaque oral microbiome ecology.

Adams SE, Arnold D, Murphy B, Carroll P, Green AK, Smith AM, Marsh PD, Chen T, Marriott RE, Brading MG.

Sci Rep. 2017 Feb 27;7:43344. doi: 10.1038/srep43344.

16.

Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.

Sharpe S, White A, Sarfas C, Sibley L, Gleeson F, McIntyre A, Basaraba R, Clark S, Hall G, Rayner E, Williams A, Marsh PD, Dennis M.

Tuberculosis (Edinb). 2016 Dec;101:174-190. doi: 10.1016/j.tube.2016.09.004. Epub 2016 Oct 8.

17.

The oral microbiome - an update for oral healthcare professionals.

Kilian M, Chapple IL, Hannig M, Marsh PD, Meuric V, Pedersen AM, Tonetti MS, Wade WG, Zaura E.

Br Dent J. 2016 Nov 18;221(10):657-666. doi: 10.1038/sj.bdj.2016.865.

18.

The effect of growth rate on pyrazinamide activity in Mycobacterium tuberculosis - insights for early bactericidal activity?

Pullan ST, Allnutt JC, Devine R, Hatch KA, Jeeves RE, Hendon-Dunn CL, Marsh PD, Bacon J.

BMC Infect Dis. 2016 May 17;16:205. doi: 10.1186/s12879-016-1533-z.

19.

Tribute.

Bostanci N, Thurnheer T, Belibasakis GN, Curtis MA, Kilian M, Marsh PD, Kinane DF, Mombelli A.

Mol Oral Microbiol. 2016 Jun;31(3):205-6. doi: 10.1111/omi.12156. Epub 2016 Apr 5. No abstract available.

20.

A Flow Cytometry Method for Rapidly Assessing Mycobacterium tuberculosis Responses to Antibiotics with Different Modes of Action.

Hendon-Dunn CL, Doris KS, Thomas SR, Allnutt JC, Marriott AA, Hatch KA, Watson RJ, Bottley G, Marsh PD, Taylor SC, Bacon J.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):3869-83. doi: 10.1128/AAC.02712-15. Print 2016 Jul.

21.

Influence of saliva on the oral microbiota.

Marsh PD, Do T, Beighton D, Devine DA.

Periodontol 2000. 2016 Feb;70(1):80-92. doi: 10.1111/prd.12098. Review.

22.

The commensal microbiota and the development of human disease - an introduction.

Marsh PD.

J Oral Microbiol. 2015 Sep 18;7:29128. doi: 10.3402/jom.v7.29128. eCollection 2015.

23.

Mycobacterium tuberculosis Is Resistant to Isoniazid at a Slow Growth Rate by Single Nucleotide Polymorphisms in katG Codon Ser315.

Jeeves RE, Marriott AA, Pullan ST, Hatch KA, Allnutt JC, Freire-Martin I, Hendon-Dunn CL, Watson R, Witney AA, Tyler RH, Arnold C, Marsh PD, McHugh TD, Bacon J.

PLoS One. 2015 Sep 18;10(9):e0138253. doi: 10.1371/journal.pone.0138253. eCollection 2015.

24.

Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques.

White AD, Sarfas C, West K, Sibley LS, Wareham AS, Clark S, Dennis MJ, Williams A, Marsh PD, Sharpe SA.

Clin Vaccine Immunol. 2015 Sep;22(9):992-1003. doi: 10.1128/CVI.00289-15. Epub 2015 Jun 24.

25.

Ecological approaches to oral biofilms: control without killing.

Marsh PD, Head DA, Devine DA.

Caries Res. 2015;49 Suppl 1:46-54. doi: 10.1159/000377732. Epub 2015 Apr 13. Review.

26.

Modulation of host responses by oral commensal bacteria.

Devine DA, Marsh PD, Meade J.

J Oral Microbiol. 2015 Feb 6;7:26941. doi: 10.3402/jom.v7.26941. eCollection 2015.

27.

Prospects of oral disease control in the future - an opinion.

Marsh PD, Head DA, Devine DA.

J Oral Microbiol. 2014 Nov 27;6:26176. doi: 10.3402/jom.v6.26176. eCollection 2014.

28.

Non-lethal control of the cariogenic potential of an agent-based model for dental plaque.

Head DA, Marsh PD, Devine DA.

PLoS One. 2014 Aug 21;9(8):e105012. doi: 10.1371/journal.pone.0105012. eCollection 2014.

29.

Non-replicating Mycobacterium tuberculosis elicits a reduced infectivity profile with corresponding modifications to the cell wall and extracellular matrix.

Bacon J, Alderwick LJ, Allnutt JA, Gabasova E, Watson R, Hatch KA, Clark SO, Jeeves RE, Marriott A, Rayner E, Tolley H, Pearson G, Hall G, Besra GS, Wernisch L, Williams A, Marsh PD.

PLoS One. 2014 Feb 6;9(2):e87329. doi: 10.1371/journal.pone.0087329. eCollection 2014.

30.

Evidence for a role for interleukin-17, Th17 cells and iron homeostasis in protective immunity against tuberculosis in cynomolgus macaques.

Wareham AS, Tree JA, Marsh PD, Butcher PD, Dennis M, Sharpe SA.

PLoS One. 2014 Feb 4;9(2):e88149. doi: 10.1371/journal.pone.0088149. eCollection 2014.

31.

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).

Marsay L, Matsumiya M, Tanner R, Poyntz H, Griffiths KL, Stylianou E, Marsh PD, Williams A, Sharpe S, Fletcher H, McShane H.

Tuberculosis (Edinb). 2013 Sep;93(5):551-7. doi: 10.1016/j.tube.2013.04.007. Epub 2013 May 31.

32.

Oral biofilms: molecular analysis, challenges, and future prospects in dental diagnostics.

Do T, Devine D, Marsh PD.

Clin Cosmet Investig Dent. 2013 Feb 28;5:11-9. doi: 10.2147/CCIDE.S31005. Print 2013.

33.

Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques.

White AD, Sibley L, Dennis MJ, Gooch K, Betts G, Edwards N, Reyes-Sandoval A, Carroll MW, Williams A, Marsh PD, McShane H, Sharpe SA.

Clin Vaccine Immunol. 2013 May;20(5):663-72. doi: 10.1128/CVI.00690-12. Epub 2013 Feb 27.

34.

Bioassay studies support the potential for iatrogenic transmission of variant Creutzfeldt Jakob Disease through dental procedures.

Kirby E, Dickinson J, Vassey M, Dennis M, Cornwall M, McLeod N, Smith A, Marsh PD, Walker JT, Sutton JM, Raven ND.

PLoS One. 2012;7(11):e49850. doi: 10.1371/journal.pone.0049850. Epub 2012 Nov 30.

35.

Method for assessing IFN-γ responses in guinea pigs during TB vaccine trials.

Tree JA, Smith S, Baker N, Clark S, Aldwell FE, Chambers M, Williams A, Marsh PD.

Lett Appl Microbiol. 2012 Oct;55(4):295-300. doi: 10.1111/j.1472-765X.2012.03292.x. Epub 2012 Aug 17.

36.

Contemporary perspective on plaque control.

Marsh PD.

Br Dent J. 2012 Jun 22;212(12):601-6. doi: 10.1038/sj.bdj.2012.524. Review.

PMID:
22722123
37.

The expression of ferritin, lactoferrin, transferrin receptor and solute carrier family 11A1 in the host response to BCG-vaccination and Mycobacterium tuberculosis challenge.

Thom RE, Elmore MJ, Williams A, Andrews SC, Drobniewski F, Marsh PD, Tree JA.

Vaccine. 2012 May 2;30(21):3159-68. doi: 10.1016/j.vaccine.2012.03.008. Epub 2012 Mar 15.

PMID:
22426328
38.

ELISPOT Refinement Using Spot Morphology for Assessing Host Responses to Tuberculosis.

Sibley LS, White AD, Marriott A, Dennis MJ, Williams A, Marsh PD, Sharpe SA.

Cells. 2012 Mar 13;1(1):5-14. doi: 10.3390/cells1010005.

39.

A quantitative assessment of residual protein levels on dental instruments reprocessed by manual, ultrasonic and automated cleaning methods.

Vassey M, Budge C, Poolman T, Jones P, Perrett D, Nayuni N, Bennett P, Groves P, Smith A, Fulford M, Marsh PD, Walker JT, Sutton JM, Raven ND.

Br Dent J. 2011 May 14;210(9):E14. doi: 10.1038/sj.bdj.2011.144.

PMID:
21372833
40.

How is the development of dental biofilms influenced by the host?

Marsh PD, Devine DA.

J Clin Periodontol. 2011 Mar;38 Suppl 11:28-35. doi: 10.1111/j.1600-051X.2010.01673.x. Review.

PMID:
21323701
41.

Temperature-dependent modulation of Porphyromonas gingivalis lipid A structure and interaction with the innate host defenses.

Curtis MA, Percival RS, Devine D, Darveau RP, Coats SR, Rangarajan M, Tarelli E, Marsh PD.

Infect Immun. 2011 Mar;79(3):1187-93. doi: 10.1128/IAI.00900-10. Epub 2011 Jan 10.

42.

Dental plaque biofilms: communities, conflict and control.

Marsh PD, Moter A, Devine DA.

Periodontol 2000. 2011 Feb;55(1):16-35. doi: 10.1111/j.1600-0757.2009.00339.x. Review. No abstract available.

PMID:
21134226
43.

Temporal changes in the gene signatures of BCG-vaccinated guinea pigs in response to different mycobacterial antigens.

Tree JA, Patel J, Thom RE, Elmore MJ, Schäfer H, Williams A, Marsh PD.

Vaccine. 2010 Nov 23;28(50):7979-86. doi: 10.1016/j.vaccine.2010.09.061. Epub 2010 Oct 23.

PMID:
20920573
44.

Oral delivery of BCG Moreau Rio de Janeiro gives equivalent protection against tuberculosis but with reduced pathology compared to parenteral BCG Danish vaccination.

Clark SO, Kelly DL, Badell E, Castello-Branco LR, Aldwell F, Winter N, Lewis DJ, Marsh PD.

Vaccine. 2010 Oct 8;28(43):7109-16. doi: 10.1016/j.vaccine.2010.07.087. Epub 2010 Aug 12.

PMID:
20708695
45.

Controlling the oral biofilm with antimicrobials.

Marsh PD.

J Dent. 2010 Jun;38 Suppl 1:S11-5. doi: 10.1016/S0300-5712(10)70005-1. Review.

PMID:
20621238
46.

Microbiology of dental plaque biofilms and their role in oral health and caries.

Marsh PD.

Dent Clin North Am. 2010 Jul;54(3):441-54. doi: 10.1016/j.cden.2010.03.002.

PMID:
20630188
47.

Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing.

Sharpe SA, McShane H, Dennis MJ, Basaraba RJ, Gleeson F, Hall G, McIntyre A, Gooch K, Clark S, Beveridge NE, Nuth E, White A, Marriott A, Dowall S, Hill AV, Williams A, Marsh PD.

Clin Vaccine Immunol. 2010 Aug;17(8):1170-82. doi: 10.1128/CVI.00079-10. Epub 2010 Jun 9.

48.

Determination of lesion volume by MRI and stereology in a macaque model of tuberculosis.

Sharpe SA, Eschelbach E, Basaraba RJ, Gleeson F, Hall GA, McIntyre A, Williams A, Kraft SL, Clark S, Gooch K, Hatch G, Orme IM, Marsh PD, Dennis MJ.

Tuberculosis (Edinb). 2009 Nov;89(6):405-16. doi: 10.1016/j.tube.2009.09.002. Epub 2009 Oct 30.

PMID:
19879805
49.

Characterisation of a live Salmonella vaccine stably expressing the Mycobacterium tuberculosis Ag85B-ESAT6 fusion protein.

Hall LJ, Clare S, Pickard D, Clark SO, Kelly DL, El Ghany MA, Hale C, Dietrich J, Andersen P, Marsh PD, Dougan G.

Vaccine. 2009 Nov 16;27(49):6894-904. doi: 10.1016/j.vaccine.2009.09.007. Epub 2009 Sep 13.

50.

Control of microbial contamination in dental unit water systems using tetra-sodium EDTA.

Percival RS, Devine DA, Nattress B, Kite P, Marsh PD.

J Appl Microbiol. 2009 Oct;107(4):1081-8. doi: 10.1111/j.1365-2672.2009.04299.x. Epub 2009 Apr 9.

Supplemental Content

Loading ...
Support Center